Process Unleashes Innovation
Strategic planning within a company must be interconnected, with a clear…
Mind vs. Machine in Asset Strategy
A well-informed asset strategy is an essential component of developing a novel…
Medical Affairs Today
The biggest risk for pre-commercial companies is being singularly focused on a…
The Right Forum, at the Right Time
Some people need to “think out loud.” Others are eager to get right to the…
100 Dots Connected: Reflecting on Eight Years of Conversations
The first edition of "Connecting the Dots" was published on September 29, 2017. Since Sue Nemetz penned that inaugural piece, 12 authors from our…
Assuming the Role of Patient
As readers of The NemetzGroup newsletter know, we often use this space to consider progress in biopharma, new technologies, and ways emerging…
The “Forcing Function” of JPM
Biopharma companies need to balance many critical priorities, especially those that are pre-commercial.
Connecting in a Volatile Job Market
What is the correct metaphor for today’s biopharma job market? A roller-coaster? A crater? A dark cloud? A correction?
A Practical Guide to Biopharma Year-End Planning
As summer winds down and vacations (sadly) come to an end, it’s a natural time to shift focus toward the close of the calendar year. Business leaders…
Building Credibility as a New Leader
Credibility is essential for leaders in any industry, but in the high-stakes world of pharma and biotech, it is even more critical.
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both exhausting and exhilarating. The decision to go in the first place depends…
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS) Global Annual Meeting. Conversations were expansive, workshops…
